MINNEAPOLIS, May 23, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three months ended March 31, 2016.
MINNEAPOLIS, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, announces the signing of a binding letter of intent for a merger transaction with
Conference call begins at 11:00 a.m. Eastern time on August 15 Definitive Merger Agreement signed, calling for issuance of Skyline common and preferred stock Skyline Medical expands revenue stream into growth markets with CytoBioscience for their ion channel screening and protein solubility
New entity will provide access to bid for $550 million in U.S. federal government funds with a focus on medical equipment for mobile operating rooms Skyline Medical to hold conference call on September 8 , 2016 at 12:00 p.m. Eastern time MINNEAPOLIS, Aug.
MINNEAPOLIS, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that stockholders have approved an amendment of the Company's